The Technical AnalystExchange: PNK Industry: Medical Devices
Heyu Biological Price, Forecast, Insider, Ratings, Fundamentals & Signals
-41.67% $0.350
America/New_York / 17 nov 2023 @ 15:19
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 361.36 mill |
| EPS: | 0 |
| P/E: | 0 |
| Earnings Date: | Mar 30, 2023 |
| SharesOutstanding: | 1 032.47 mill |
| Avg Daily Volume: | 0.0005 mill |
| RATING 2023-12-15 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Strong Sell | |
| DE: | Strong Sell | |
| P/E: | Buy | |
| Price To Book: | Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 2/22 | 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | |
| Revenue | n/a | |||||
| Gr.Profit | n/a | |||||
| Ebit | ||||||
| Asset | ||||||
| Debt | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 0 | sector: PE -11.58 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| N/A |
| Company: PE 0 | industry: PE -6.92 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$-0.0006 (-100.16%) $-0.351 |
| Date: 2024-03-15 |
| Expected Trading Range (DAY) |
|---|
|
$ 0.249 - 0.321 ( +/- 12.62%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2023-09-28 | Ang Ban Siong | Sell | 28 328 194 | Common Stock |
| 2023-09-04 | Gao Xingjia | Buy | 0 | |
| 2023-09-04 | Li Wei | Buy | 0 | |
| 2023-09-01 | Lin Zengqiang | Buy | 0 | Common stock, par value $0.001 |
| 2023-09-01 | Lin Zhenzhu | Buy | 0 | Common stock, par value $0.001 |
| INSIDER POWER |
|---|
| -68.39 |
| Last 69 transactions |
| Buy: 26 831 300 | Sell: 207 052 757 |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $0.350 (-41.67% ) |
| Volume | 0.0004 mill |
| Avg. Vol. | 0.0005 mill |
| % of Avg. Vol | 74.30 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For HYBT
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
HYBT
Heyu Biological Technology Corporation, together with its subsidiaries, engages in research, development, and manufacturing of healthcare equipment. It is currently focused on developing Submillimeter Wave (Terahertz) Quantized Space Therapy Chamber, a medical equipment designed to treat cancer through cold nuclear fusion caused by cosmic ray muons in an enclosed chamber. The company was formerly known as Pacific WebWorks, Inc. and changed its name to Heyu Biological Technology Corporation in June 2018. Heyu Biological Technology Corporation was incorporated in 1987 and is based in Xiamen, the People's Republic of China.